MedPath

Clinical Study on the Treatment of Foot Cell Injury in Diabetic Nephropathy Patients with Chinese Medicine Xiaoke Decoctio

Phase 2
Conditions
Diabetic nephropathy
Registration Number
ITMCTR2000003856
Lead Sponsor
Shanghai Traditional Chinese Medicine Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

A total of 40 patients aged 30-75 years from January 2020 to September 2021 were collected from the outpatient department of nephropathy of diabetes in our hospital. All of them met the diagnostic criteria of the world health organization (WHO) for DM in 1999 and were diagnosed as diabetic stage iiiiv urinary albumin/urinary creatinine ratio (UACR) >30mg/g according to the Mogensen diabetes staging criteria.

Exclusion Criteria

Patients with macrovascular disease, chronic nephritis, congestive heart failure, fever, urinary tract infection, malignant tumor and other diseases were excluded. No recent history of taking nephrotoxic drugs was found.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Blood sugar;Nephrin;The activity of histone deacetylase (HDAC).;Blood uric acid;Podocin;Uroprotein quantification;Serum creatinine;Blood urea nitrogen;
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath